The largest contributors to Q4 performance were Microsoft, Amazon, and Workday, and the largest detractors were Aon and Regeneron; Novo Nordisk was the smallest contributor.
A new position in Novo Nordisk was initiated and we sold the portfolio’s position in Regeneron. We trimmed positions in ServiceNow, Workday, and Salesforce on strength during the quarter and reallocated capital to positions in Danaher, CPKC, Autodesk, and UnitedHealth on weakness.